MorphoSys AG (MOR) Q2 2020 Earnings Conference Call August 6, 2020 8:00 AM ET
Company Participants
Anja Pomrehn - Head of IR
Jean-Paul Kress - CEO
Jens Holstein - CFO
Malte Peters - Chief Research and Development Officer
Roland Wandeler - COO
Conference Call Participants
Jason Butler - JMP Securities
Geoffrey Porges - SVB Leerink
Paul Jeng - Guggenheim Securities
Christian Ehmann - FMR Research
Marcus Wieprecht - MainFirst Bank
Operator
Ladies and gentlemen, good afternoon or good morning. My name is Anja Pomrehn, Head of Investor Relations at MorphoSys. It's my pleasure to welcome you to our Q2 2020 results conference call and webcast.
With me on the call today are Jean-Paul Kress, Chief Executive Officer; Jens Holstein, Chief Financial Officer; Malte Peters, Chief Research and Development Officer; and Roland Wandeler, Chief Operating Officer.
Before we start, I would like to remind you that some of the statements made during the call today are forward-looking statements, including statements regarding our expectations for the commercialization of our products and our development plans, the impact of COVID-19 on our business and expectations for the compounds in our pipeline as well as the development plans of our collaboration partners.
These forward-looking statements are subject to a number of risks and uncertainties that may cause our actual results to differ material, including those described in MorphoSys 20-F and annual report or for the year ended December 31, 2019, and from time to time in other SEC documents of MorphoSys. It is important to keep in mind that our statements on this webcast speak as of today.
Readers and listeners are requested to refer to Slide 2. You will find the agenda of today's call on Slide 3. Jean-Paul will provide an overview of the highlights in the second quarter 2020. Jens, then will talk you through the
- Read more current MOR analysis and news
- View all earnings call transcripts